Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability

Lipid nanoparticles (LNPs) are currently in the spotlight as delivery systems for mRNA therapeutics and have been used in the Pfizer/BioNTech and Moderna COVID-19 vaccines. mRNA-LNP formulations have been indicated to require strict control, including maintenance at fairly low temperatures during th...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariko Kamiya (Author), Makoto Matsumoto (Author), Kazuma Yamashita (Author), Tatsunori Izumi (Author), Maho Kawaguchi (Author), Shusaku Mizukami (Author), Masako Tsurumaru (Author), Hidefumi Mukai (Author), Shigeru Kawakami (Author)
Format: Book
Published: MDPI AG, 2022-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available